Medical TPU Selection: How Sterilization, Biocompatibility, and Processing Change the Validation Plan
“Is this a medical-grade TPU?” sounds like a material question, but a reliable answer requires a device context. Contact type and duration, sterilization route, processing, additives, bonding, packaging, shelf life, market, documentation, and finished-device performance all shape the qualification plan.
Quick answer
A supplier’s “medical grade” designation or ISO 10993 test package can support material screening, but it does not approve the finished device. Start with intended use and patient contact, identify the exact grade and formulation, process representative parts, expose representative finished devices to the validated cycle parameters—or the specified radiation dose range—including justified worst-case conditions and the maximum number of exposures where applicable, age them in the planned packaging, and then evaluate biological, chemical, mechanical, visual, and functional endpoints under the device manufacturer’s or regulatory sponsor’s risk-management and regulatory process.
Do not assume that every TPU tolerates ethylene oxide, gamma, electron beam, vaporized hydrogen peroxide (VH₂O₂, often called VHP), dry heat, or steam in the same way. Sterilization can change color, molecular structure, extractables, surface, clarity, dimensions, bonding, and mechanical behavior. Compatibility must be demonstrated for the exact material–process–sterilization–device system.
“Medical grade,” biological evaluation, and device approval are different
Term or evidence | What it can support | What it does not prove |
|---|---|---|
Supplier “medical grade” designation | A defined grade may include controlled formulation, quality documentation, testing, and change-notification practices. | It is not a universal legal category and does not approve every contact type, duration, or device. |
ISO 10993 data on resin or coupon | Useful input to a risk-based biological evaluation when the tested formulation and extraction conditions are relevant. | It does not automatically transfer to a processed, colored, bonded, printed, sterilized, and packaged finished device. |
Sterilization compatibility statement | A supplier may identify routes studied for a named grade under stated conditions. | It does not establish unlimited cycles, all doses, all properties, or sterility assurance for the device. |
Regulatory letter or master-file support | Can assist submissions and supplier qualification in named jurisdictions. | It is not the device manufacturer’s clearance, approval, or conformity assessment. |
Passed prototype tests | Shows evidence for tested samples and conditions. | It does not replace lot controls, process validation, shelf-life evidence, or change control. |
FDA’s ISO 10993-1 guidance frames biological evaluation as a risk-based assessment for the final device in its intended use. The necessary endpoints depend on nature and duration of contact, materials and manufacturing, available information, and identified risks. FDA does not clear or approve individual materials used to manufacture medical devices; depending on the pathway, FDA may clear, approve, authorize, grant, or exempt the finished device. Supplier designations and ISO 10993 data are supporting evidence, not FDA authorization of a resin or finished device. Confirm the latest jurisdiction-specific guidance with qualified regulatory and toxicology specialists.
Start with use, contact, and device function
- Device and clinical function: tubing, catheter, connector, film, dressing, wearable patch, pump component, enclosure, or another use.
- Patient contact: direct or indirect, tissue/fluid contacted, intact or breached surface, and contact duration/category.
- Mechanical duty: kink radius, pressure, flow, flex cycles, puncture, tensile/tear, creep, abrasion, seal integrity, and connection loads.
- Exposure: drugs, lipids, saline, blood, disinfectants, skin oils, sweat, cleaners, temperature, humidity, oxygen, and light.
- Optical and surface needs: clarity, radiopacity, color, printability, lubricity, tack, particulate generation, and surface treatment.
- Regulatory and quality needs: target markets, applicable standards, biocompatibility plan, extractables/leachables strategy, traceability, supplier controls, and change notification.
Sterilization routes can change different properties
Route | Material/process questions | Validation focus |
|---|---|---|
Ethylene oxide (EtO) | Gas exposure, temperature, humidity, packaging permeability, aeration, and residuals. | Color/clarity, dimensions, mechanical function, bonding, EtO/ECH residuals as applicable, packaging, and repeat cycles. |
Gamma irradiation | Total dose, dose range/uniformity, oxygen, temperature, additives, pigments, and polymer sensitivity. | Molecular change, color, surface, extractables, tensile/elongation, kink/pressure function, bonding, and aging interaction. |
Electron beam | Dose and dose rate, penetration, geometry/density, packaging, and polymer sensitivity. | Same material endpoints as radiation routes plus dose mapping for the product configuration. |
Vaporized hydrogen peroxide (VH₂O₂ / VHP) | Oxidative exposure, concentration, dwell/aeration, material surfaces, and device lumen limitations. | Surface chemistry, discoloration, cracking, tack, residues, bonding, and device-function cycles. |
Dry heat | Temperature and time versus TPU softening, relaxation, oxidation, and packaging limits. | Dimensions, creep/warpage, color, mechanical retention, seal/bond, and packaging integrity. |
Steam/autoclave | Heat plus moisture can be severe for some TPU chemistries and assemblies. | Hydrolysis, softening, dimensions, clarity, bond/print, packaging, and functional performance; do not assume suitability. |
Material compatibility testing does not establish sterility assurance. The device manufacturer or regulatory sponsor must separately develop, validate, and routinely control the sterilization process and demonstrate that the sterile-barrier system and device remain acceptable through the claimed shelf life. Route-specific references may include ISO 11135 and ISO 10993-7 for EtO, ISO 11137-1:2025 for radiation, ISO 17665:2024 for moist heat, and ISO 22441:2022 for VH₂O₂; confirm the current, applicable editions for the target market.
A 2023 peer-reviewed study of one medical TPU processed by fused-deposition modeling and then gamma sterilized found measurable molecular-weight changes through processing and after irradiation, while tensile performance in that study was not significantly affected by irradiation. The correct lesson is not that “gamma is safe for TPU.” It is that processing and sterilization can alter the polymer in different ways and should be evaluated together for the exact formulation and application.
Processing and assembly change the evaluated material system
Process variable | Possible consequence | Evidence to retain |
|---|---|---|
Drying and moisture | Hydrolysis during melt processing, bubbles, lower molecular weight, appearance or strength changes. | Grade instructions, dryer conditions, measured moisture, exposure time after drying. |
Melt temperature and residence time | Thermal degradation, color, viscosity shift, gels, extractables, and mechanical loss. | Actual melt/pressure/load trends, startup/shutdown, purge, lot and cavity/line traceability. |
Extrusion or molding orientation | Anisotropy, residual stress, shrinkage, kink or tear behavior. | Representative geometry, direction-marked specimens, dimensions, conditioning, and process window. |
Colorants and additives | Biological/chemical profile, radiation color response, bonding, surface, and documentation may change. | Exact approved formulation and supplier documents; no unqualified substitutions. |
Printing, coating, lubricant, adhesive | New patient-contacting substances, residues, delamination, curing products, or extractables. | Full bill of materials, cure/process data, interface tests, and chemical characterization strategy. |
Regrind or mixed streams | Traceability, thermal history, contamination, property drift, and regulatory evidence gaps. | Written policy, segregation, controlled trials, risk assessment, and explicit approval; avoid by default for sensitive uses. |
Build a staged validation plan
Stage | Purpose | Typical outputs |
|---|---|---|
1. Intended-use and evidence map | Translate clinical use and markets into material, biological, sterilization, and functional requirements. | Contact category/duration, risk questions, standards/guidance list, documentation gaps, acceptance criteria. |
2. Exact grade and formulation screen | Confirm candidate identity, supply controls, processing range, and available evidence. | TDS/SDS, composition disclosures as appropriate, quality/change-control documents, supplier test reports. |
3. Processed coupon and component | Capture real drying, heat, shear, orientation, pigments, surface treatment, and assembly. | Process window, dimensions, appearance, chemistry/extractables screen, baseline mechanical/function tests. |
4. Sterilized product configuration | Expose representative parts and packaging to minimum/maximum dose or validated cycle range. | Post-sterilization color, surface, chemistry, mechanical, bond, flow/kink/leak, and packaging results. |
5. Aging and repeat-cycle evaluation | Assess claimed shelf life, distribution, in-use period, or reprocessing if applicable. | Accelerated/real-time aging rationale, retained function, packaging integrity, biological/chemical evidence. |
6. Release and change control | Keep commercial production equivalent to qualified evidence. | Incoming controls, lot traceability, critical process limits, deviations, supplier-change review, periodic monitoring. |
Where TPU may fit—and where another direction may be more suitable
- TPU can be a useful candidate for flexible tubing, catheter components, films, selected wound-care or wearable layers, and molded parts where elasticity, toughness, clarity, kink resistance, or thermoplastic processing are valuable.
- A purpose-designed medical TPU portfolio with suitable documentation is a more credible starting point than a general industrial grade for direct or indirect patient-contact applications.
- Another polymer or specialist grade may be a more suitable candidate when the requirement includes repeated high-temperature steam, long-term implantation, highly aggressive drug/fluid exposure, extremely low extractables, specialized gas permeability, or an established regulatory history that the candidate TPU cannot support.
- If GOAFLEX cannot provide the needed grade-specific documentation, quality controls, or change-notification support, the feasibility review should identify that gap early rather than imply medical suitability.
A practical pre-sample checklist
- Intended device, component function, patient-contact path and duration, target countries, development stage, and risk classification if known.
- Drawing and dimensions: wall thickness, lumen, bend radius, connection, pressure/flow, film stack, seal, bond, or overmold geometry.
- Required hardness, flexibility, clarity, color, kink/pressure, tensile/tear, puncture, abrasion, recovery, and dimensional targets.
- Fluids, drugs, disinfectants, sweat/skin exposure, temperature, humidity, light, and contact time.
- Processing: extrusion/molding/film route, equipment, drying, melt window, colorants/additives, bonding, printing, coating, lubricant, and packaging.
- Sterilization route, target and maximum dose/cycle, number of cycles, packaging configuration, aeration, and shelf-life claim.
- Required supplier evidence: biological-test reports, chemical characterization support, quality system, lot traceability, formulation controls, change notification, and regulatory letters.
- Acceptance tests on the finished device, current candidate/failure samples, comparative reports, forecast volume, and timeline.
Send the intended use, contact profile, exact process, sterilization route/cycles, required documentation, and finished-device tests to hello@goaflex.com for an initial feasibility discussion. GOAFLEX material screening does not replace medical-device regulatory, toxicological, sterilization, or finished-device validation. For general TPU fundamentals, see https://www.goaflex.com/blog/what-is-tpu-thermoplastic-polyurethane-guide
Related GOAFLEX guides
For adjacent material and processing context, see TPU drying and moisture control, TPU chemical-resistance validation, polyether vs. polyester TPU for tubing and hose and TPU fundamentals and selection.
Sources and further reading
- FDA — Use of ISO 10993-1 — https://www.fda.gov/regulatory-information/search-fda-guidance-documents/use-international-standard-iso-10993-1-biological-evaluation-medical-devices-part-1-evaluation-and — risk-based, device-specific biological-evaluation guidance; verify current revision and jurisdiction.
- FDA — Sterilization for medical devices — https://www.fda.gov/medical-devices/general-hospital-devices-and-supplies/sterilization-medical-devices — overview of established and novel sterilization methods and validation context.
- ISO — ISO 10993-1:2025 — https://www.iso.org/standard/10993-1 — current biological-evaluation framework within a risk-management process; confirm FDA transition and target-market recognition for the submission strategy.
- ISO — ISO 10993-18 — https://www.iso.org/standard/64750.html — chemical characterization of device materials and process-, sterilization-, extractable-, leachable-, and degradation-related constituents.
- Covestro — TPU in healthcare — https://solutions.covestro.com/en/highlights/articles/stories/2025/tpu-in-healthcare — supplier-specific examples for catheters, tubing, films, sterilization routes, and regulatory support; do not generalize claims.
- M’Bengue et al., Pharmaceutics (2023) — https://pmc.ncbi.nlm.nih.gov/articles/PMC9960613/ — open-access study showing why TPU processing and gamma sterilization should be evaluated together; results apply to the studied system.
- GOAFLEX — What Is TPU? — https://www.goaflex.com/blog/what-is-tpu-thermoplastic-polyurethane-guide — general TPU chemistry, processing, and application-selection background.
Image credits
Image 1: Central venous catheter equipment; cropped from the licensed source image. The body crop and square featured-image crop are adaptations. Creator/source: Clinical_Cases. https://commons.wikimedia.org/wiki/File:Central_line_equipment.jpg. License: CC BY-SA 2.5.
Image 2: Healthcare sterilizer in a Norwegian dental clinic; contextual heat-sterilization image. Creator/source: Bjoertvedt. https://commons.wikimedia.org/wiki/File:Sterilizer_Getinge_HS11k3_IMG_0569.JPG. License: CC BY-SA 3.0.
Image 3: Gamma-irradiation center; contextual radiation-sterilization image. Creator/source: Naveenp69. https://commons.wikimedia.org/wiki/File:Cobalta-Gamma_irradiation_for_safest_sterilization.jpg. License: CC BY-SA 4.0.
Image 4: Two transdermal patch constructions; exact polymer materials are not identified. Creator/source: AlisonW. https://commons.wikimedia.org/wiki/File:Transdermal_patches.jpg. License: CC BY-SA 3.0.
Context note: These search-sourced, commercially reusable images illustrate application, testing, or sterilization context. They do not prove GOAFLEX ownership of the photographed products, creator endorsement, exact TPU chemistry or grade, medical suitability, regulatory status, or performance of any GOAFLEX material.
Intellectual property notice: If any information or material in this article is believed to violate intellectual property rights, contact GOAFLEX so it can be reviewed and addressed.
